Advertisement

Archives of Dermatological Research

, Volume 304, Issue 5, pp 343–351 | Cite as

Association of TGFβ1 and clinical factors with scar outcome following melanoma excision

  • Sarah V. WardEmail author
  • G. Cadby
  • J. S. Heyworth
  • M. W. Fear
  • H. J. Wallace
  • J. M. Cole
  • F. M. Wood
  • L. J. Palmer
Original Paper

Abstract

All patients with primary cutaneous malignant melanoma undergo surgical excision to remove the tumour, resulting in scar formation. There is marked variation in the aesthetic appearance of scars following surgery but limited knowledge about the genetic factors affecting non-keloid, surgical scar outcomes. This study aimed to investigate the role of known clinical factors and genetic polymorphisms in pigmentation and wound repair genes in non-keloid scar outcome, following melanoma excision. Participants were 202 cases who underwent a standardized scar assessment following surgical melanoma excision and provided a DNA sample. Genetic association analyses between single nucleotide polymorphisms (SNPs) from 24 candidate genes and scar outcome data were performed, controlling for relevant clinical factors. Following adjustment for multiple testing, SNP rs8110090 in TGFβ1 was significantly associated with both the primary scar outcome (a combination score reflecting vascularity, height and pliability, p = 0.0002, q = 0.01) and the secondary scar outcome (a combination score reflecting vascularity, height, pliability and pigmentation, p = 0.0002, q = 0.006). The minor allele G was associated with a poorer scar outcome. Younger age, time elapsed since excision, absence of kidney failure and eczema, presence of thyroid problems and infection were also associated with poorer scar outcome and were adjusted for in the final model, along with scar site. Results from this study suggest that genes involved in wound healing may play a role in determining scar outcome. Associations observed between scar outcome and clinical factors reinforce current clinical knowledge regarding factors affecting scarring. Replication studies in larger samples are warranted and will improve our understanding of the underlying mechanisms of scarring, potentially help to identify patients at risk of poor scar outcomes.

Keywords

Scar outcome Non-keloid Melanoma TGFβWound repair genes Pigmentation genes 

Notes

Acknowledgments

The authors gratefully acknowledge all participants for their time and contribution, as well as the Western Australian Cancer Registry, the Western Australian DNA Bank (National Health and Medical Research Council Enabling Facility), the Ark at The University of Western Australia, the McComb Foundation staff, the Royal Perth Hospital Medical Imaging Department, all scar examiners, Ms Nicole Warrington, the WAMHS study team and the WAMHS Management Committee. This research was supported by funding from the Scott Kirkbride Melanoma Research Centre and the Australian Government Department of Innovation, Industry, Science and Research (Australian Postgraduate Awards)

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

403_2012_1240_MOESM1_ESM.pdf (98 kb)
Supplementary material 1 (PDF 98 kb)
403_2012_1240_MOESM2_ESM.pdf (48 kb)
Supplementary material 2 (PDF 48 kb)
403_2012_1240_MOESM3_ESM.pdf (48 kb)
Supplementary material 3 (PDF 48 kb)

References

  1. 1.
    Al-Attar A, Mess S, Thomassen J, Kauffman C, Davison S (2006) Keloid pathogenesis and treatment. Plast Reconstr Surg 117(1):286–300PubMedCrossRefGoogle Scholar
  2. 2.
    Anitha B, Ragunatha S, Inamadar AC (2008) Scars in dermatology: clinical significance. Indian J Dermatol Venereol Leprol 74(4):420–423PubMedCrossRefGoogle Scholar
  3. 3.
    Ashcroft GS, Kielty CM, Horan MA, Ferguson MWJ (1997) Age-related changes in the temporal and spatial distributions of fibrillin and elastin mRNAS and proteins in acute cutaneous wounds of healthy humans. J Pathol 183(1):80–89PubMedCrossRefGoogle Scholar
  4. 4.
    Baryza M, Baryza G (1995) The Vancouver scar scale: an administration tool and its interrater reliability. J Burn Care Rehabil 16(5):535–538PubMedCrossRefGoogle Scholar
  5. 5.
    Bataille V, de Vries E (2008) Melanoma-Part 1: epidemiology, risk factors, and prevention. BMJ 337:1287–1291CrossRefGoogle Scholar
  6. 6.
    Benjamini Y, Yekutieli D (2001) The control of the false discovery rate in multiple testing under dependency. Ann Stat 29(4):1165–1188CrossRefGoogle Scholar
  7. 7.
    Blobe G, Schiemann W, Lodish H (2000) Role of transforming growth factor β in human disease. N Engl J Med 342(18):1350–1358PubMedCrossRefGoogle Scholar
  8. 8.
    Bond J, Duncan JAL, Sattar A, Boanas A, Mason T, O’Kane S, Ferguson MW (2008) Maturation of the human scar: an observational study. Plast Reconstr Surg 121(5):1650–1658PubMedGoogle Scholar
  9. 9.
    Broughton G, Janis JE, Attinger CE (2006) The basic science of wound healing. Plast Reconstr Surg June Supplement 2006:12S–34SCrossRefGoogle Scholar
  10. 10.
    Brown J, Bayat A (2009) Genetic susceptibility to raised dermal scarring. Br J Dermatol 161:8–18PubMedCrossRefGoogle Scholar
  11. 11.
    Brusselaers N, Pirayesh A, Hoeksema H, Verbelen J, Blot S, Monstrey S (2010) Burn scar assessment: a systematic review of objective scar assessment tools. Burns 36:1157–1164PubMedCrossRefGoogle Scholar
  12. 12.
    de Bakker P, Yelensky R, Pe’er I, Gabriel S, Daly M, Altshuler D (2005) Efficiency and power in genetic association studies. Nat Genet 37:1217–1223PubMedCrossRefGoogle Scholar
  13. 13.
    Draaijers L, Tempelman F, Botman Y, Tuinebreijer W, Middelkoop E, Kreis R, van Zuijlen P (2004) The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg 113(7):1960–1965PubMedCrossRefGoogle Scholar
  14. 14.
    Durani P, McGrouther DA, Ferguson MWJ (2009) Current scales for assessing human scarring: a review. J Plast Reconstr Aesthet Surg 62:713–720PubMedCrossRefGoogle Scholar
  15. 15.
    Eming S, Hammerschmidt M, Krieg T, Roers A (2009) Interrelation of immunity and tissue repair or regeneration. Semin Cell Dev Biol 20:517–527PubMedCrossRefGoogle Scholar
  16. 16.
    Eming SA, Krieg T, Davidson JM (2007) Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 127(3):514–525PubMedCrossRefGoogle Scholar
  17. 17.
    Ferguson M, O’Kane S (2004) Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 359:839–850PubMedCrossRefGoogle Scholar
  18. 18.
    Fitzpatrick T (1975) Soleil et peau. J Med Esthet 2:33–34Google Scholar
  19. 19.
    International HapMap Project. http://hapmap.ncbi.nlm.nih.gov/index.html.en. Accessed 27 July 2009
  20. 20.
    Liew Y, McLaughlin R, Wood FM, Sampson D (2011) Reduction of image artifacts in three-dimensional optical coherence tomography of skin in vivo. J Biomed Opt 16(11):116018PubMedCrossRefGoogle Scholar
  21. 21.
    Liu W, Wang DR, Cao YL (2004) TGF-β: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther 4(1):123–136PubMedCrossRefGoogle Scholar
  22. 22.
    Louw L (2007) The Keloid phenomenon: progress toward a solution. Clin Anat 20:3–14PubMedCrossRefGoogle Scholar
  23. 23.
    Marcus JR, Tyrone JW, Bonomo S, Xia Y, Mustoe TA (2000) Cellular mechanisms for diminished scarring with aging. Plast Reconstr Surg 105(5):1591–1599PubMedCrossRefGoogle Scholar
  24. 24.
    Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215PubMedCrossRefGoogle Scholar
  25. 25.
    Newton-Bishop JA, Nolan C, Turner F, McCabe M, Boxer C, Thomas JM, Coombes G, A’Hern RP, Barrett JH (2004) A quality-of-life study in high-risk (thickness ≥2 mm) cutaneous melanoma patients in a randomized trial of 1-cm versus 3-cm surgical excision margins. J Invest Dermatol Symp Proc 9(2):152–159CrossRefGoogle Scholar
  26. 26.
    Pho L, Leachman S (2010) Genetics of pigmentation and melanoma predisposition. G Ital Dermatol Venereol 145(1):37–45PubMedGoogle Scholar
  27. 27.
    R-Development-Core-Team (2008) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org
  28. 28.
    Rapoport B, McLachlan S (2001) Thyroid autoimmunity. J Clin Invest 108(9):1253–1259PubMedGoogle Scholar
  29. 29.
    Redd M, Cooper L, Wood W, Stramer BM, Martin P (2004) Wound healing and inflammation: embryos reveal the way to perfect repair. Philos Trans R Soc Lond 359:777–784CrossRefGoogle Scholar
  30. 30.
    Robins S, Milne G, Duncan A, Davies C, Butt R, Greiling D, James I (2003) Increased skin collagen extractability and proportions of collagen type III are not normalized after 6 months healing of human excisional wounds. J Invest Dermatol 121(2):267–272PubMedCrossRefGoogle Scholar
  31. 31.
    Robson M, Steed D, Franz M (2001) Wound healing: biologic features and approaches to maximize healing trajectories. Curr Probl Surg 38(2):72–140PubMedCrossRefGoogle Scholar
  32. 32.
    Seifert O, Mrowietz U (2009) Keloid scarring: bench and bedside. Arch Dermatol Res 301(4):259–272PubMedCrossRefGoogle Scholar
  33. 33.
    Shih B, Bayat A (2010) Genetics of keloid scarring. Arch Dermatol Res 302(5):319–339PubMedCrossRefGoogle Scholar
  34. 34.
    Sullivan T, Smith J, Kermode J, McIver E, Courtemanche D (1990) Rating the burn scar. J Burn Care Rehabil 11(3):256–260PubMedCrossRefGoogle Scholar
  35. 35.
    Téot L (2002) Clinical evaluation of scars. Wound Repair Regen 10(2):93–97PubMedCrossRefGoogle Scholar
  36. 36.
    Truong PT, Abnousi F, Yong CM, Hayashi A, Runkel JA, Phillips T, Olivotto IA (2005) Standardized assessment of breast cancer surgical scars integrating the Vancouver Scar Scale, Short-Form McGill Pain Questionnaire, and patients’ perspectives. Plast Reconstr Surg 116(5):1291–1299PubMedCrossRefGoogle Scholar
  37. 37.
    Tuan T-L, Nichter LS (1998) The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4(1):19–24PubMedCrossRefGoogle Scholar
  38. 38.
    Tucker M, Goldstein A (2003) Melanoma etiology: where are we? Oncogene 22:3042–3052PubMedCrossRefGoogle Scholar
  39. 39.
    van Zuijlen P, Angeles A, Kreis R, Bos K, Middelkoop E (2002) Scar assessment tools: implications for current research. Plast Reconstr Surg 109(3):1108–1122PubMedCrossRefGoogle Scholar
  40. 40.
    Ward S, Cadby G, Lee A, Cole J, Heyworth J, Millward M, Wood F, Palmer L (2011) The Western Australian Melanoma Health Study: study design and participant characteristics. Cancer Epidemiol 35(5):423–431PubMedCrossRefGoogle Scholar
  41. 41.
    Widgerow A, Chait L, Stals R, Stals P (2000) New innovations in scar management. Aesthetic Plast Surg 24:227–234PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Sarah V. Ward
    • 1
    Email author
  • G. Cadby
    • 2
  • J. S. Heyworth
    • 3
  • M. W. Fear
    • 4
    • 5
    • 6
  • H. J. Wallace
    • 4
  • J. M. Cole
    • 7
  • F. M. Wood
    • 4
    • 5
  • L. J. Palmer
    • 2
    • 8
  1. 1.Centre for Genetic Epidemiology and BiostatisticsThe University of Western AustraliaCrawleyAustralia
  2. 2.Samuel Lunenfeld Research InstituteTorontoCanada
  3. 3.School of Population HealthThe University of Western AustraliaCrawleyAustralia
  4. 4.Burn Injury Research UnitThe University of Western AustraliaCrawleyAustralia
  5. 5.McComb FoundationTelstra Burns Reconstruction and Rehabilitation UnitPerthAustralia
  6. 6.School of MedicineUniversity of Notre Dame AustraliaFremantleAustralia
  7. 7.St John of God Dermatology, St John of God Health Care SubiacoSubiacoAustralia
  8. 8.Genetic Epidemiology and Biostatistics PlatformOntario Institute for Cancer Research, MaRS CentreTorontoCanada

Personalised recommendations